Anti-Hu CD164 PE

*Doyonnas R, Yi-Hsin Chan J, Butler LH, Rappold I, Lee-Prudhoe JE, Zannettino AC, Simmons PJ, Bühring HJ, Levesque JP, Watt SM: CD164 monoclonal antibodies that block hemopoietic progenitor cell adhesion and proliferation interact with the first mucin domain of the CD164 receptor. J Immunol. 2000 Jul 15;165 (2) :840-51., URL: http://www.ncbi.nlm.nih.gov/pubmed/10878358 , *Jorgensen-Tye B, Levesque JP, Royle L, Doyonnas R, Chan JY, Dwek RA, Rudd PM, Harvey DJ, Simmons PJ, Watt SM: Epitope recognition of antibodies that define the sialomucin, endolyn (CD164), a negative regulator of haematopoiesis. Tissue Antigens. 2005 Mar;65 (3) :220-39., URL: https://pubmed.ncbi.nlm.nih.gov/15730515/, *Pilling D, Vakil V, Gomer RH: Improved serum-free culture conditions for the differentiation of human and murine fibrocytes. J Immunol Methods. 2009 Dec 31;351 (1-2) :62-70., URL: https://www.ncbi.nlm.nih.gov/pubmed/19818792, *Hennersdorf F, Florian S, Jakob A, Baumgärtner K, Sonneck K, Nordheim A, Biedermann T, Valent P, Bühring HJ: Identification of CD13, CD107a, and CD164 as novel basophil-activation markers and dissection of two response patterns in time kinetics of IgE-dependent upregulation. Cell Res. 2005 May;15 (5) :325-35., URL: http://www.ncbi.nlm.nih.gov/pubmed/15916720